These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2904696

  • 1. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.
    Lohr JB, Cadet JL, Lohr MA, Larson L, Wasli E, Wade L, Hylton R, Vidoni C, Jeste DV, Wyatt RJ.
    Schizophr Bull; 1988; 14(2):291-6. PubMed ID: 2904696
    [Abstract] [Full Text] [Related]

  • 2. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB, Caligiuri MP.
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [Abstract] [Full Text] [Related]

  • 3. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
    Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, Raisch D, Caligiuri M, Tracy K.
    Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
    [Abstract] [Full Text] [Related]

  • 4. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H, Geraisy N, Schwartz M.
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [Abstract] [Full Text] [Related]

  • 5. The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects.
    McCreadie RG, MacDonald E, Wiles D, Campbell G, Paterson JR.
    Br J Psychiatry; 1995 Nov; 167(5):610-7. PubMed ID: 8564316
    [Abstract] [Full Text] [Related]

  • 6. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY, Zhou DF, Cao LY, Xu CQ, Chen DC, Wu GY.
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [Abstract] [Full Text] [Related]

  • 7. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study.
    Bai YM, Chou KH, Lin CP, Chen IY, Li CT, Yang KC, Chou YH, Su TP.
    Schizophr Res; 2009 Apr; 109(1-3):167-81. PubMed ID: 19261444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term treatment effects of vitamin E for tardive dyskinesia.
    Adler LA, Edson R, Lavori P, Peselow E, Duncan E, Rosenthal M, Rotrosen J.
    Biol Psychiatry; 1998 Jun 15; 43(12):868-72. PubMed ID: 9627740
    [Abstract] [Full Text] [Related]

  • 12. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.
    Cavallaro R, Regazzetti MG, Mundo E, Brancato V, Smeraldi E.
    Neuropsychopharmacology; 1993 May 15; 8(3):233-9. PubMed ID: 8099483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K, Rathbone J.
    Cochrane Database Syst Rev; 2006 Jan 25; (1):CD000459. PubMed ID: 16437425
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I, Oumaya A, Bouguerra C, Mehdi F, Bellaaj R, Gallali S.
    Encephale; 2013 May 25; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J, Lima MS, Costa AN, Alexandrino N, Rodrigues-Filho S, de Oliveira IR, Tollefson GD.
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec 25; 254(6):356-61. PubMed ID: 15538607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Awareness of tardive dyskinesia in Asian patients with schizophrenia.
    Chong SA, Remington G, Mahendran R, Chua HC.
    J Clin Psychopharmacol; 2001 Apr 25; 21(2):235-7. PubMed ID: 11270922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.